Bookmark
Forward
Anti-PD-1 for pretreated advanced anal carcinoma: which patients will benefit?
Astrid Lièvre
The lancet. Gastroenterology & hepatology 2022 May
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Astrid Lièvre.
Anti-PD-1 for pretreated advanced anal carcinoma: which patients will benefit?
The lancet. Gastroenterology & hepatology.
2022 May;7(5):384-386
Mesh Tags
Antineoplastic Agents, Immunological
Anus Neoplasms
Carcinoma
Humans
Substances
Antineoplastic Agents, Immunological
PMID: 35114168
View Full Text